| Literature DB >> 34838076 |
Hairui Fu1,2, Bin Liang2, Wei Qin3, Xiaoxiong Qiao4, Qiang Liu5.
Abstract
BACKGROUND: No prognostic model for the survival of fragile hip fracture has been developed for Asians. The goal of this study was to develop a simple and practical prognostic model to predict survival within 1 year after fragile hip fracture in Asians.Entities:
Keywords: Development; Fragile hip fracture; Prognostic model; Survival
Mesh:
Substances:
Year: 2021 PMID: 34838076 PMCID: PMC8626932 DOI: 10.1186/s13018-021-02774-y
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Fig. 1Telephone interview flow chart. (Note: -P: primary; -L: last; -S: surgery; -D: death; Y: yes; N: no; dotted arrow: performed only if ALI-A be no)
Fig. 2The characteristics of missing data. Note: Blue means no missing and red means missing. The label above the graph represents candidate predictors, the below represents the missing number of each candidate predictor, the left represents the number of observations with the same missing pattern, and the right represents the number of types with missing predictors. For instance, ALB predictor has 13 missing values. There are four observations missing both ALB and LD
Optimal coding exploration for continuous predictors (complete case analysis)
| Predictor | Coding | Waldχ2 | ||
|---|---|---|---|---|
| Age | Linear | 24.96 | 1 | < .0001 |
| RCS (3) | 22.03 | 2 | < .0001 | |
| RCS (4) | 23.90 | 3 | < .0001 | |
| RCS (5) | 23.62 | 4 | 0.0001 | |
| BS | Linear | 0.61 | 1 | 0.4345 |
| RCS (3) | 0.77 | 2 | 0.6798 | |
| RCS (4) | 5.66 | 3 | 0.1291 | |
| RCS (5) | 6.39 | 4 | 0.1719 | |
| SC | Linear | 13.27 | 1 | 0.0003 |
| RCS (3) | 12.77 | 2 | 0.0017 | |
| RCS (4) | 13.94 | 3 | 0.0030 | |
| RCS (5) | 13.96 | 4 | 0.0074 | |
| Log | 11.25 | 1 | 0.0008 | |
| Hb | Linear | 10.19 | 1 | 0.0014 |
| RCS (3) | 15.14 | 2 | 0.0005 | |
| RCS (4) | 14.65 | 3 | 0.0021 | |
| RCS (5) | 15.36 | 4 | 0.0040 | |
| ALB | Linear | 33.97 | 1 | < .0001 |
| RCS (3) | 31.76 | 2 | < .0001 | |
| RCS (4) | 31.30 | 3 | < .0001 | |
| RCS (5) | 32.07 | 4 | < .0001 |
Fig. 3Participant flow diagram
Participant characteristics
| Characteristic | Missing values, | Value |
|---|---|---|
| Mean age (years) | 0 | 74.8(SD, 9.5) (range 50–103) |
| Male | 0 | 279 (38.0%) |
| Medical insurance | 0 | |
| Employee medical insurance (EMI) | 101 (13.7%) | |
| Non-EMI | 634 (86.3%) | |
| Fracture site | 0 | |
| Femoral neck | 305 (41.5%) | |
| Intertrochanteric | 413 (56.2%) | |
| Subtrochanteric | 17 (2.3%) | |
| Fracture type | 0 | |
| Primary | 689 (93.7%) | |
| Secondary | 46 (6.3%) | |
| Fracture to admitted (d) | 0 | 2.3 (SD, 5.9) (range 0–62) |
| Admitted to surgery (d) (637patients) # | 0 | 5.5 (SD, 3.3) (range 1–45) |
| Length of stay (LOS) | 0 | 13.0 (SD, 6.4) (range 1–52) |
| Diabetes | 0 | 116 (15.8%) |
| Hypertension (HYP) | 0 | 357 (48.6%) |
| Malignancy (MLA) | 0 | 18 (2.4%) |
| Kidney disease (KD) | 0 | 11 (1.5%) |
| Lung disease (LD) | 58 (7.9%) | 271 (36.9%) |
| Ability of living independence (ALI) (no = 0, yes = 1) | 0 | 107 (14.6%) (no = 0) |
| Cardiovascular and cerebrovascular diseases (CCD) | 0 | 295 (40.1%) |
| Blood sugar (BS)(mmol/L) | 9 (1.2%) | 6.8 (SD 2.4) (range 3.4–21.6) |
| Serum creatinine (SC) (μmol/L)* | 9 (1.2%) | 70.3 (SD, 23.8) (range 26.0–190.8) |
| Hemoglobin (Hb)(g/L) | 9 (1.2%) | 117.8 (SD, 20.1) (range 43–179) |
| Albumin (ALB)(g/L) | 13 (1.8%) | 37.9 (SD, 4.1) (range 21.8–48.2) |
| Mean arterial pressure (MAP) (mmHg) | 0 | 104.8 (SD, 16.2) (range 56–182) |
| Partial pressure of oxygen (PaO2) (mmHg) | 212 (28.8%) | 75.4 (SD, 17.4) (range 33–176) |
| Total protein (TP) (g/L) | 16 (2.2%) | 63.4 (SD, 6.8) (range 44.6–105.0) |
| Skeletal traction | 0 | 375 (51.0%) |
| Surgery | 9 (1.2%) | 637 (86.7%) |
SD: standard deviation
*Means the SC value was winsorized; before this, the mean was 72.14 μmol/L (SD, 42.6) and the range was [26.0, 860.0]
#Means it includes only 637 patients who were operated on in our hospital
Association between each predictor and outcome from the SI dataset
| Characteristic | Patients with an outcome (n = 68) | Patients without an outcome (n = 667) | Univariate hazard ratios (95% | Full model hazard ratios(95% | LASSO model hazard ratios(95% |
|---|---|---|---|---|---|
| Age (years) ( | 80 ( | 74 ( | 2.7 (1.8, 4.0) | 2.2 (1.4, 3.5) | 1.8 (1.2, 2.8) |
| Sex (Female = 0, Male = 1, | 35 (51.5%) (Male) | 244 (36.6%) (Male) | 1.7 (1.1, 2.8) | 1.7 (1.0, 2.8) | 1.4 (0.8, 2.2) |
| MLA (No = 0, Yes = 1, | 5 (7.4%) (Yes) | 13 (1.9%) (Yes) | 3.2 (1.3, 7.9) | 4.1 (1.4, 11.9) | 2.7 (1.0, 7.7) |
| LD (No = 0, Yes = 1, | 34 (50.0%) (Yes) | 266 (39.9%) (Yes) | 1.5 (1.0, 2.5) | 1.0 (0.6, 1.7) | - |
| ALI (No = 0, Yes = 1, | 15 (22.1%) (No) | 92 (13.8%) (No) | 1.7 (0.9, 3.0) | 1.5 (0.8, 2.9) | 1.3 (0.7, 2.5) |
| CCD (No = 0, Yes = 1, | 37 (54.4%) (Yes) | 258 (38.7%) (Yes) | 1.8 (1.1, 3.0) | 1.5 (0.9, 2.6) | 1.4 (0.8, 2.4) |
| HYP (No = 0, Yes = 1, | 34 (50.0%) (Yes) | 323 (48.4%) (Yes) | 1.1 (0.7, 1.7) | 1.5 (0.8, 2.5) | 1.2 (0.7, 2.0) |
| BS (mmol/L) ( | 6.9 ( | 6.8 ( | 1.0 (0.9, 1.2) | 1.1 (0.9, 1.2) | – |
| SC (μmol/L) ( | 80.1 ( | 69.2 ( | 1.3 (1.1, 1.6) | 1.2 (1.0, 1.5) | 1.2 (1.0, 1.4) |
| ALB(g/L) ( | 35.1 ( | 38.1 ( | 0.4 (0.3, 0.6) | 0.6 (0.4, 0.8) | 0.6 (0.5, 0.9) |
| Hb(g/L) ( | 111.2 ( | 118.4 ( | 0.6 (0.5, 0.9) | 1.1 (0.7, 1.5) | – |
| SUR (No = 0, Yes = 1, | 30 (44.1%) (No) | 59 (8.8%) (No) | 6.9 (4.3, 11.2) | 5.2 (3.1, 8.7) | 4.8 (2.9, 8.0) |
SD: standard deviation; CI: confidence interval
Presenting the model, including the baseline survival, for 1-year survival (from the SI dataset)
| Predictors | The full model | The LASSO model | ||||
|---|---|---|---|---|---|---|
| β coefficient | SE | β coefficient | SE | |||
| Age (linear) | 0.0567 | 0.0167 | 0.0007 | 0.0421 | 0.0156 | 0.0070 |
| Sex = 1 (Female = 0, Male = 1) | 0.5125 | 0.2591 | 0.0479 | 0.3047 | 0.2567 | 0.2352 |
| MLA = 1 (No = 0, Yes = 1) | 1.4137 | 0.5430 | 0.0092 | 1.0000 | 0.5333 | 0.0608 |
| LD = 1 (No = 0, Yes = 1) | – 0.0083 | 0.2625 | 0.9746 | – | – | – |
| ALI = 1 (No = 0, Yes = 1) | – 0.4368 | 0.3268 | 0.1813 | – 0.2721 | 0.3253 | 0.4028 |
| CCD = 1 (No = 0, Yes = 1) | 0.4075 | 0.2781 | 0.1428 | 0.3432 | 0.2754 | 0.2126 |
| HYP = 1 (No = 0, Yes = 1) | 0.3837 | 0.2807 | 0.1716 | 0.1713 | 0.2743 | 0.5322 |
| BS (linear) | 0.0350 | 0.0448 | 0.4345 | – | – | – |
| SC (linear) | 0.0091 | 0.0041 | 0.0284 | 0.0080 | 0.0041 | 0.0502 |
| ALB (linear) | – 0.1001 | 0.0336 | 0.0029 | – 0.0819 | 0.0310 | 0.0082 |
| Hb (linear) | 0.0020 | 0.0067 | 0.7659 | – | – | – |
| SUR = 1 (No = 0, Yes = 1) | – 1.6523 | 0.2592 | < 0.0001 | – 1.5734 | 0.2546 | < 0.0001 |
S0 = 0.984 (1-year baseline survival)
“–” means that this variable was removed during the LASSO shrinking process
Fig. 4Nomogram based on the LASSO model. Note: For example, a man (SEX = 1.3) with fragility hip fracture, 80 years old (age = 5.1), no malignant tumor (MLA = 0), self-care ability well (ALI = 0), having cerebral infarction history (CCD = 1.4) and no hypertension (HYP = 0), serum creatinine 100 μmol/L (S C = 2.6), albumin 42 g/L ( ALB = 2.7), and choosing conservative treatment (SUR = 6.4), so the total score = 19.5, the 1-year survival close to 0.8 or 80%. The corresponding 1-year mortality is 20%
A simple scoring system for calculating the survival/mortality
| Predictor | Variable range | Score range | Total score | Survival | Mortality |
|---|---|---|---|---|---|
| Age (years) | 50–105 | 0–9.4 | 15.4 | 0.9 | 0.1 |
| Sex (Female = 0, Male = 1) | 0 | 0 | 20 | 0.8 | 0.2 |
| 1 | 1.3 | 22 | 0.7 | 0.3 | |
| MLA (No = 0, Yes = 1) | 0 | 0 | 23 | 0.6 | 0.4 |
| 1 | 4 | 24.3 | 0.5 | 0.5 | |
| ALI (No = 0, Yes = 1) | 0 | 1.1 | 25.5 | 0.4 | 0.6 |
| 1 | 0 | 26.6 | 0.3 | 0.7 | |
| CCD (No = 0, Yes = 1) | 0 | 0 | 27.8 | 0.2 | 0.8 |
| 1 | 1.4 | 29.2 | 0.1 | 0.9 | |
| SUR (No = 0, Yes = 1) | 0 | 6.4 | |||
| 1 | 0 | ||||
| SC (μmol/L) | 20–200 | 0–5.8 | |||
| ALB (g/L) | 20–50 | 10–0 | |||
| HYP (No = 0, Yes = 1) | 0 | 0 | |||
| 1 | 0.7 |
The predicted survival probability of the patient with fragility hip fracture within 1 year after fracture is calculated by p = 0.984exp (0.042*Age+0.305*SEX+MLA−0.272*ALI+0.343*CCD−1.573*SUR+0.008*SC−0.082*ALB+0.171*HYP); the corresponding mortality rate is 1-p
Fig. 5Kaplan–Meier curves for three risk groups of low, middle, and high
Model performance measures
| Performance measures | Full model | LASSO model | ||||
|---|---|---|---|---|---|---|
| Original | Internal validation (B = 1000) | Optimism | Original | Internal validation (B = 1000) | Optimism | |
| C | 0.816 | 0.790 | 0.026 | 0.814 | 0.795 | 0.019 |
| R2 | 0.188 | 0.147 | 0.041 | 0.187 | 0.158 | 0.030 |
Fig. 6Relative contribution of each predictor to the full LASSO prediction model